Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitisTiago Torres, Mario Valenti, Anna Balato, et al.
Frontiers in Pharmacology|April 23, 2025
Assessment of competencies of clinical research professionals and proposals to improve clinical research in PortugalMónica Bogas, Joana Antas, Cátia Magalhães, et al.
Dermatology and Therapy|June 3, 2025
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort StudyTiago Torres, Jensen Yeung, Vimal H Prajapati, et al.
American Journal of Clinical Dermatology|August 17, 2022
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping studyEmma Vyvey, Rani Soenen, Hazel H Oon, et al.
ARP Rheumatology|January 4, 2025
CheckAP: Prevalence of psoriatic arthritis (PsA) and performance evaluation of the EARP questionnaire in the population of Portuguese patients with psoriasis followed in a dermatology settingAna Rita Henriques, Fernando Pimentel-Santos, João Teles de Sousa, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitisTiago Torres, Mario Valenti, Anna Balato, et al.
Frontiers in Pharmacology|April 23, 2025
Assessment of competencies of clinical research professionals and proposals to improve clinical research in PortugalMónica Bogas, Joana Antas, Cátia Magalhães, et al.
Dermatology and Therapy|June 3, 2025
Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort StudyTiago Torres, Jensen Yeung, Vimal H Prajapati, et al.
American Journal of Clinical Dermatology|August 17, 2022
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort StudyTiago Torres, Luis Puig, Ron Vender, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort studyAndrea Chiricozzi, Giulia Coscarella, Luis Puig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping studyEmma Vyvey, Rani Soenen, Hazel H Oon, et al.
ARP Rheumatology|January 4, 2025
CheckAP: Prevalence of psoriatic arthritis (PsA) and performance evaluation of the EARP questionnaire in the population of Portuguese patients with psoriasis followed in a dermatology settingAna Rita Henriques, Fernando Pimentel-Santos, João Teles de Sousa, et al.
The British Journal of Dermatology|February 1, 2022
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional surveyKatie Bechman, Emma S Cook, Nick Dand, et al.
The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.
Pageof 28